T +1 212 819 8695
Ross Elfand is a partner in White & Case's Global Competition group. He concentrates on complex civil and criminal commercial litigation and antitrust counseling.
As part of the Firm's pro bono efforts, Mr. Elfand participated in the Firm's externship program with inMotion, Inc., where he represented and counseled indigent women who were victims of domestic violence in matrimonial and family law matters. During the three-month externship, Mr. Elfand served as lead counsel on numerous cases at the same time and appeared in court on a weekly basis.
In re Aggrenox Antitrust Litigation—Representing Boehringer Ingelheim in class action multidistrict litigation arising from alleged delay in generic competition to Aggrenox, due to a claimed "reverse payment" patent settlement.
Pfizer v. J&J—Representing Pfizer in litigation alleging that J&J engaged in a multifaceted exclusionary contracting scheme to foreclose biosimilar competition to Remicade.
Defended a global company in a criminal price-fixing investigation brought by the Department of Justice, Antitrust Division.
Successful defense of multi-billion-dollar "opt-out" price-fixing antitrust case in electronics industry, winning defense verdict after seven-week jury trial in Northern District of California.
Successful defense of multi-billion-dollar class-action price-fixing antitrust case in electronics industry; prevailed after six-week federal jury trial in Northern District of California, with client owing no damages.
Fair Isaac Corporation v. Equifax, et al. (2011)—Secured dismissal of antitrust claims lodged by Fair Isaac Corporation against Experian, stemming from the formation by the three major US credit bureaus of a competing consumer credit scoring service. Secured favorable jury verdict for Experian in trademark claims asserted by Fair Isaac. The Eighth Circuit Court of Appeals affirmed both the antitrust dismissal and the jury's verdict.
Leegin Might Turn Out to Have a Lot of Class, Antitrust Practitioner, Volume 6, August 2007